Hint mode is switched on Switch off
For swift navigation between sections

Organization: Takeda Pharmaceutical
LEI 549300ZLMVP4X0OGR454

Organization name
Takeda Pharmaceutical Company Limited
Country name
Japan
Country of registration
Japan
Industry
Pharmaceutical Preparation and Biotechnology
Bond debt
18,968 mln USD

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Latest data on

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company in Japan. The companys drugs are marketed in approximately 90 countries worldwide. The company has an international marketing network, including Japan and 13 overseas bases in the U.S., Europe, and Asia. From these bases, the company markets its original products.The company operates its business in two categories, Pharmaceutical business and Other businesses. The Pharmaceutical business represents the ethical drug business and healthcare business. Other businesses include business activities involving the production and marketing of a range of products, including clinical diagnostics, photographic chemicals, and inorganic chemicals. In November 2009, Amylin Pharmaceuticals Inc. and Takeda Pharmaceutical Co. Ltd. announced that they have entered into a worldwide exclusive license, development and commercialization agreement to co-develop and commercialize pharmaceutical products for the treatment of obesity and related indications.Takeda Pharmaceutical Company Limited was founded in 1781.

Awards

Documentation

Stocks

Latest issues

Bond debt by currency

Codes

  • LEI
    549300ZLMVP4X0OGR454
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • CIK
    0001395064

Credit and ESG Ratings

Macroeconomic Indicators - Takeda Pharmaceutical

Registration is required to get access.